glp 1 semaglutide for weight loss Before & After GLP-1 Semaglutide Weight Loss Injections in

T2D type 2 diabetes 1

Arendt JFH, Hansen AT, Ladefoged SA, Srensen HT, Pedersen L, Adelborg K

In the longer term, reduced obesity rates among Medicaid enrollees could also result in reduced Medicaid spending on chronic diseases associated with obesity, though the evidence is mixed

Semaglutide (Wegovy) and liraglutide (Saxenda) are the primary weight loss injections licensed in the UK for weight management, and both list headaches as a recognised adverse effect in their Summary of Product Characteristics (SmPC)

2 This pandemic of obesity has placed a substantial burden on healthcare systems and patients alike, sparking intense interest in the development of novel therapeutic strategies

Blood Sugar Stability Supports the Whole System Large blood sugar swings can leave people feeling hungry, tired, irritable, and snacky